Key Events This Week
22 Jun: Stock surged to Rs.160.80, up 4.38%
23 Jun: Slight dip to Rs.160.10 amid broader market weakness
24 Jun: Rebounded to Rs.162.85 with strong volume
25 Jun: New 52-week and all-time high at Rs.164.90
26 Jun: Week closed at Rs.161.75, down 0.68% on the day
22 June: Strong Opening Rally Amid Positive Market Sentiment
Amanta Healthcare Ltd began the week on a robust note, closing at Rs.160.80, a gain of 4.38% from the previous close. This surge was well ahead of the Sensex’s 0.46% rise to 36,342.26 points. The volume of 14,598 shares indicated healthy investor interest. The stock’s strong start set the tone for the week, reflecting renewed momentum in the Pharmaceuticals & Biotechnology sector.
23 June: Minor Correction Amid Broader Market Weakness
The stock experienced a slight pullback, closing at Rs.160.10, down 0.44% on the day. This decline occurred against a backdrop of a significant Sensex drop of 1.05%, which closed at 35,959.97. The stock’s relative resilience amid the market sell-off suggested underlying support. Volume dipped slightly to 13,191 shares, reflecting cautious trading ahead of midweek developments.
24 June: Recovery with Increased Delivery Volumes
Amanta Healthcare rebounded strongly to Rs.162.85, up 1.72%, supported by a volume spike to 15,602 shares. Delivery volumes accounted for 18.50% of total volume, a notable increase compared to the 5-day average of 4,940 shares. This surge in delivery volume indicated genuine buying interest rather than speculative trading. The Sensex also recovered, gaining 0.53% to 36,151.68, but Amanta outperformed the benchmark comfortably.
Under the radar no more! This Large Cap from Cement is emerging from turnaround with solid fundamentals intact. Discover it while it's still relatively hidden!
- - Hidden turnaround gem
- - Solid fundamentals confirmed
- - Large Cap opportunity
25 June: New 52-Week and All-Time Highs Amid Mixed Technical Signals
The stock reached a significant milestone by touching Rs.164.90, its new 52-week and all-time high. Despite closing lower at Rs.161.75 (-0.68%), the intraday peak underscored strong buying interest. This price level surpassed key moving averages including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained upward momentum.
However, the day’s performance was mixed as the broader Sensex gained 0.14%, and the Pharmaceuticals & Biotechnology sector outperformed Amanta by 0.4%. Intraday volatility was evident with a low of Rs.156.50, a 3.9% drop from the peak, reflecting profit-taking or short-term caution.
Technical indicators presented a nuanced picture: bullish weekly MACD and Bollinger Bands contrasted with a bearish weekly RSI, suggesting potential short-term overbought conditions. The Dow Theory assessment was mildly bearish weekly but bullish monthly, indicating a complex trend environment. On-balance volume was bullish on a monthly basis, supporting the recent price gains.
Valuation metrics at close included a trailing twelve months P/E of 39 times, P/BV of 2.87 times, and EV/EBITDA of 13.10 times, reflecting a premium pricing consistent with the stock’s micro-cap status. The company’s Mojo Score stood at 44.0, corresponding to a 'Sell' grade as of 15 June 2026, reflecting cautious analyst sentiment despite the price rally.
26 June: Week Ends with Slight Decline Amid Consolidation
The week concluded with the stock closing at Rs.161.75, down 0.68% from the previous day’s close. Trading volume dropped to 6,618 shares, indicating a quieter session. The Sensex also declined marginally by 0.05% to 36,133.32. This slight pullback may represent consolidation after the recent sharp gains and record highs, as investors digest the week’s developments.
Holding Amanta Healthcare Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Weekly Price Performance: Amanta Healthcare vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-06-22 | Rs.160.80 | +4.38% | 36,342.26 | +0.46% |
| 2026-06-23 | Rs.160.10 | -0.44% | 35,959.97 | -1.05% |
| 2026-06-24 | Rs.162.85 | +1.72% | 36,151.68 | +0.53% |
| 2026-06-25 | Rs.161.75 | -0.68% | 36,133.32 | -0.05% |
Key Takeaways
Positive Signals: Amanta Healthcare demonstrated strong relative strength this week, gaining 5.00% while the Sensex declined slightly. The stock’s new 52-week and all-time highs at Rs.164.90 highlight renewed momentum and technical strength. Increased delivery volumes on 24 June indicate genuine investor interest. The stock remains above key moving averages, supporting a constructive medium-term outlook.
Cautionary Notes: Despite the price gains, the Mojo Score remains at 44.0 with a 'Sell' grade, reflecting underlying fundamental concerns. Technical indicators such as the weekly RSI and Dow Theory suggest short-term caution. The stock’s valuation multiples are elevated relative to earnings and book value, consistent with its micro-cap status but warranting careful monitoring. Intraday volatility on 25 June and the slight pullback on 26 June suggest consolidation may be underway.
Conclusion
Amanta Healthcare Ltd’s performance this week was marked by a notable 5.00% gain, driven by the achievement of new 52-week and all-time highs and supported by increased trading volumes. The stock outperformed the Sensex comfortably, reflecting sector-specific momentum within Pharmaceuticals & Biotechnology. However, mixed technical signals and a cautious analyst rating underscore the importance of balanced assessment. Investors should weigh the recent price strength against valuation and fundamental considerations as the stock consolidates after its recent rally.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
